Toronto, April 27, 2020 – MORSE Consulting is pleased to release our April 2020 Update to the Canadian Reimbursement Trends and Timelines report – a comprehensive, credible and relevant source of market access intelligence.
This 50+ PowerPoint report is aimed at assisting market access professionals plan for future launches and also serves as a valuable education tool for both internal and external stakeholders.
What’s New in the April 2020 Update?
- Full coverage of the 2019 pCPA Calendar Year as well as comparisons with previous years.
- Jurisdictional funding update of 2018 completed negotiations & 2019 completed negotiations, complete with metrics stratified by oncology & non-oncology subtypes.
- Market Access Timelines from CADTH Submission to public listing in each jurisdiction, stratified by oncology & non-oncology.
Please click here to learn more about our new report.
About the Authors:
MORSE Consulting Inc. is a leader in strategic pharmaceutical market access consulting in Canada. Our team has significant expertise in reimbursement strategy in a wide range of therapeutic areas and has built a reputation for providing meaningful strategic insights. MORSE has established strong, constructive relationships with healthcare stakeholders and a proven track record for delivering impactful results to its clients.
